2018
DOI: 10.1016/j.msard.2017.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
16
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 12 publications
3
16
1
Order By: Relevance
“…In this study, cognition impairment, fatigue, and pain were reported by 40.7, 62.6, and 46.3%, respectively, throughout the course of the disease. Similar to these findings, previous studies reported that more than half of patients with NMOSD suffered from the above symptoms in different regions among different ethnicities (12,16,37,38). To be noted, 76.4% of patients reported suffering from negative emotions in our current study.…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…In this study, cognition impairment, fatigue, and pain were reported by 40.7, 62.6, and 46.3%, respectively, throughout the course of the disease. Similar to these findings, previous studies reported that more than half of patients with NMOSD suffered from the above symptoms in different regions among different ethnicities (12,16,37,38). To be noted, 76.4% of patients reported suffering from negative emotions in our current study.…”
Section: Discussionsupporting
confidence: 91%
“…These differences in findings indicate that although NMOSD causes severe neurological dysfunctions, the psychological resilience of patients may be differentiated between ethnicities with different genetic and environmental backgrounds. Notably, the physical and emotional disorders of patients with NMOSD often lead to certain high-risk behaviors, such as self-harm and suicide ( 16 ). A more recent study exploring mortality and causes of death among 569 Chinese patients with NMOSD indicated that 8.3% of patients died due to suicide during a 10-year follow-up ( 17 ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…More than 44% of patients experienced depression, although most cases were mild, and remarkably no patients scored within the severe category. Our prevalence and severity were lower than in studies measuring depression prevalence among NMOSD in Argentina, the USA, and Germany [ 34 , 36 , 37 ]; however, pain and disability were higher in these cohorts, and ethnicity also differed. It should be noted that our results on depression were similar to those reported by Yalachkov et al, as both populations had similar disease duration, low physical disability, and the same questionnaire was used, although the fast screen BDI questionnaire was used in our sample [ 15 ].…”
Section: Discussioncontrasting
confidence: 89%
“…Based on a retrospective analysis of a US administrative claims database, the prevalence of depression in patients with NMO (n=1,349) and highly active NMO (n=134; defined as at least two relapses within twelve months of the patient's first NMO encounter in the database) was estimated at 17.9% and 25.4%, respectively. 34 Fernandez et al found that ten patients with NMOSD (50%) had current depressive symptoms versus five (28%) patients with MS (p=0.16). 35 Six (30%) patients with NMOSD versus only one (5.5%) patient with MS had attempted suicide at least once (p=0.05).…”
Section: Discussionmentioning
confidence: 97%